MARATTO

article · ChemistrySelect

Design, Synthesis, and Anti‐Inflammatory Evaluation In Vitro and In Silico of Novel Flavone Derivatives

20253 citationsOpen accessMohamed I University

Abstract

Abstract A series of flavone derivatives (4–6) were synthesized via cyclization of 2′ hydroxychalcones 3 into flavonols 4 using the Algar–Flynn–Oyamada reaction. Flavonols 4 were then O ‐cyanomethylated to flavones 5, followed by click coupling to obtain flavone‐tetrazole derivatives 6. The inhibitory ability of synthesized compounds on the production of pro‐inflammatory mediators (nitric oxide and interleukin‐1β) was also investigated. From the obtained results, it appears that only products 3b , 5c , 6a , and 6b at concentrations lower than 56.8 µg/mL have inhibitory ability on the production of NO from lipopolysaccharide‐activated RAW 264.7 cells. In contrast, the other compounds, particularly derivatives 3c , 4b‐c , and 5a‐b , exhibit pro‐inflammatory activity even at low concentrations. For IL‐1α release from THP‐1 cells induced with LPS, flavones bearing the O ‐cyanopropyl group (5a‐c) significantly lowered the production of this pro inflammatory mediator with the concentration lower than 32 µg/mL. The significant interactions of compound 5a‐c with the caspase‐1 protein shown by the molecular docking consolidated the inhibitory activity of these O ‐cyanopropyl flavones. Therefore, these results suggest that compounds 5a‐c can represent a useful starting point for the development of new treatments of the inflammatory disease.

Research topics

  • Synthesis of Organic Compounds
  • Flavonoids in Medical Research
  • Natural product bioactivities and synthesis

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1002/slct.202405663

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.